TABLOID
NDC 80725-630, thioguanine, tablet, from Waylis Therapeutics LLC.
- Product NDC
- 80725-630
- Status
- Listed
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA012429
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80725-630 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THIOGUANINE40 mg/1
Pharmacologic classes
Antimetabolite [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80725-630-25 | 80725063025 | 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/44b0c461-47fb-4106-ba11-6ed85530235c
Use it
Look up 80725-630 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80725-630 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80725-630. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.